Knowledge hub

News

Conferences – where can you find us in February?

Holiday Wishes
Ardigen and The BioCollective partner to detect early signs of Parkinson’s Disease for better diagnosis and treatment.
5 years for precision medicine – Ardigen’s anniversary
AI aided design of epitope-based vaccine for the induction of cellular immune responses against SARS-CoV-2
Agnieszka Blum, PhD MD, joins Ardigen as the General Director of Immunology
Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapies
Ardigen enters into research collaboration with CVC to apply Artificial Intelligence for identification of T-cell targets – press release
AACR poster -2
Microbial signatures of response to anti-PD1 therapy in metastatic melanoma patients
News

AACR poster – 1
Accounting for immune escape mechanisms in personalized and shared neoantigen cancer vaccine design

Selvita and Ardigen will receive funding for the development of an AI-based high-content screening platform
We are ready to support your efforts in the fight against COVID-19
The microbiome as a potential weapon against novel coronavirus SARS-CoV-2
Ardigen at AI Powered Drug Discovery and Manufacturing Conference
A new publication about molecule property prediction: Molecule Attention Transformer
A new report about the use of medical data to develop AI in Poland
Ardigen at PMWC 2020
New microbiome and phenotype data from observational study will enlarge unique Ardigen’s database